548 related articles for article (PubMed ID: 18281170)
1. Stability of luciferase plasmid entrapped in cationic bilayer vesicles.
Manosroi A; Thathang K; Werner RG; Schubert R; Manosroi J
Int J Pharm; 2008 May; 356(1-2):291-9. PubMed ID: 18281170
[TBL] [Abstract][Full Text] [Related]
2. Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles.
Manosroi A; Khositsuntiwong N; Götz F; Werner RG; Manosroi J
J Liposome Res; 2009; 19(2):91-8. PubMed ID: 19241277
[TBL] [Abstract][Full Text] [Related]
3. Development of highly stable and low toxic cationic liposomes for gene therapy.
Manosroi A; Thathang K; Werner RG; Schubert R; Peschka-Süss R; Manosroi J
Arzneimittelforschung; 2008; 58(10):485-92. PubMed ID: 19025056
[TBL] [Abstract][Full Text] [Related]
4. Expression of luciferase plasmid (pCMVLuc) entrapped in DPPC/cholesterol/DDAB liposomes in HeLa cell lines.
Manosroi A; Thathang K; Manosroi J; Werner RG; Schubert R; Peschka-Süss R
J Liposome Res; 2009; 19(2):131-40. PubMed ID: 19515000
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium.
Manosroi A; Jantrawut P; Manosroi J
Int J Pharm; 2008 Aug; 360(1-2):156-63. PubMed ID: 18539416
[TBL] [Abstract][Full Text] [Related]
6. Entrapment enhancement of peptide drugs in niosomes.
Manosroi A; Khanrin P; Werner RG; Götz F; Manosroi W; Manosroi J
J Microencapsul; 2010 May; 27(3):272-80. PubMed ID: 20113169
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of niosomes prepared by supercritical carbon dioxide (scCO2) fluid.
Manosroi A; Chutoprapat R; Abe M; Manosroi J
Int J Pharm; 2008 Mar; 352(1-2):248-55. PubMed ID: 18036754
[TBL] [Abstract][Full Text] [Related]
8. Cationic niosomes composed of spermine-based cationic lipids mediate high gene transfection efficiency.
Paecharoenchai O; Niyomtham N; Ngawhirunpat T; Rojanarata T; Yingyongnarongkul BE; Opanasopit P
J Drug Target; 2012 Nov; 20(9):783-92. PubMed ID: 22931523
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
[TBL] [Abstract][Full Text] [Related]
10. Membrane interactions of ternary phospholipid/cholesterol bilayers and encapsulation efficiencies of a RIP II protein.
Manojlovic V; Winkler K; Bunjes V; Neub A; Schubert R; Bugarski B; Leneweit G
Colloids Surf B Biointerfaces; 2008 Jul; 64(2):284-96. PubMed ID: 18359207
[TBL] [Abstract][Full Text] [Related]
11. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol.
Devaraj GN; Parakh SR; Devraj R; Apte SS; Rao BR; Rambhau D
J Colloid Interface Sci; 2002 Jul; 251(2):360-5. PubMed ID: 16290741
[TBL] [Abstract][Full Text] [Related]
12. Membrane properties of cationic liposomes composed of dipalmitoylphosphatidylcholine and dipalmityldimethylammonium bromide.
Yokoyama S; Inagaki A; Imura T; Ohkubo T; Tsubaki N; Sakai H; Abe M
Colloids Surf B Biointerfaces; 2005 Sep; 44(4):204-10. PubMed ID: 16087320
[TBL] [Abstract][Full Text] [Related]
13. Physical stability of different liposome compositions obtained by extrusion method.
Armengol X; Estelrich J
J Microencapsul; 1995; 12(5):525-35. PubMed ID: 8544096
[TBL] [Abstract][Full Text] [Related]
14. Potent enhancement of transdermal absorption and stability of human tyrosinase plasmid (pAH7/Tyr) by Tat peptide and an entrapment in elastic cationic niosomes.
Manosroi J; Khositsuntiwong N; Manosroi W; Götz F; Werner RG; Manosroi A
Drug Deliv; 2013; 20(1):10-8. PubMed ID: 23311648
[TBL] [Abstract][Full Text] [Related]
15. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
17. Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity.
Saravolac EG; Ludkovski O; Skirrow R; Ossanlou M; Zhang YP; Giesbrecht C; Thompson J; Thomas S; Stark H; Cullis PR; Scherrer P
J Drug Target; 2000; 7(6):423-37. PubMed ID: 10758913
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and anti-proliferative activity of azelaic acid and its derivatives entrapped in bilayer vesicles in cancer cell lines.
Manosroi A; Panyosak A; Rojanasakul Y; Manosroi J
J Drug Target; 2007 Jun; 15(5):334-41. PubMed ID: 17541842
[TBL] [Abstract][Full Text] [Related]
19. Span and Tween neutral and pH-sensitive vesicles: characterization and in vitro skin permeation.
Carafa M; Marianecci C; Rinaldi F; Santucci E; Tampucci S; Monti D
J Liposome Res; 2009; 19(4):332-40. PubMed ID: 19863168
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of transdermal absorption, gene expression and stability of tyrosinase plasmid (pMEL34)-loaded elastic cationic niosomes: potential application in vitiligo treatment.
Manosroi J; Khositsuntiwong N; Manosroi W; Götz F; Werner RG; Manosroi A
J Pharm Sci; 2010 Aug; 99(8):3533-41. PubMed ID: 20213835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
